Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neupath Health Inc. ( (TSE:NPTH) ) just unveiled an announcement.
NeuPath Health Inc., a Canadian operator of one of the country’s largest networks of community-based multidisciplinary pain management clinics, focuses on chronic and musculoskeletal pain, back pain, sports medicine and other pain-related services within the publicly funded healthcare system. The company emphasizes improved access to care and patient outcomes through specialized, team-based treatment models.
NeuPath plans to settle $420,000 in performance-based bonus debt owed to its former CEO and current CFO by issuing 893,616 common shares at $0.47, aligning executives with future equity upside while preserving cash. The move follows a period of significantly improved financial performance, will lift insider ownership to about 13%, and remains subject to TSX Venture Exchange and disinterested shareholder approval under related-party and security-based compensation rules.
The most recent analyst rating on (TSE:NPTH) stock is a Buy with a C$0.58 price target. To see the full list of analyst forecasts on Neupath Health Inc. stock, see the TSE:NPTH Stock Forecast page.
More about Neupath Health Inc.
NeuPath Health Inc. operates one of Canada’s largest networks of community-based, multidisciplinary medical facilities focused on chronic pain, musculoskeletal and back pain, sports medicine and related pain services. Working within Canada’s publicly funded healthcare system, it aims to improve patient access and outcomes through best-in-class treatments and patient-centered multidisciplinary care.
Average Trading Volume: 90,526
Technical Sentiment Signal: Buy
Current Market Cap: C$25.57M
Find detailed analytics on NPTH stock on TipRanks’ Stock Analysis page.